基本信息
浏览量:117
职业迁徙
个人简介
Research interests: diabetes, non-alcoholic fatty liver disease, cancer and arteriosclerosis
These were the old days in which there were no available treatment to treat lipoprotein disorders. Once available these tools we moved to a time in which there were no suitable treatment for atherosclerosis and other non-communicable diseases, or at least, much deeper knowledge is required to manage these diseases. In this context, the trajectory has been long and successful, mainly due to the quality of the human and material resources arranged and leadership to meet planned goals. As a result of combined work, the Unit has trained many PhD students with successful careers in clinical research and have been published more than 400 articles, as well as books, book chapters, clinical guides, and other teaching material. The key to lead clinical and research teams is relatively simple when considering and taking advantage of the ideas and abilities of each member, managing emotions and maintaining goals oriented to motivate continuous improvement. The Unit has demonstrated ability to manage more than 80 projects including clinical trials, commitments to related Industries and academic competitive projects. The Unit has been steadily extending a complex collaboration network throughout Spain, Europe and the United States. The last 10 years have been oriented towards understanding obesity and its metabolic complications, especially diabetes, non-alcoholic fatty liver disease, cancer and arteriosclerosis, the leading causes of morbidity and mortality worldwide. It is now clear that deciphering key mechanisms coordinating nutrition, metabolism, epigenetics, oxidation and inflammation may lead to combined and effective treatments. Current challenges include the understanding of the metabolo-epigenetics clues governing metabolic flexibility and disease-induced metabolic reprogramming. In pursuing these goals, we have learned, not without fuss, that working alone allows reaching limited goals more quickly and without excessive effort, but that we go much further by forming multidisciplinary teams.
These were the old days in which there were no available treatment to treat lipoprotein disorders. Once available these tools we moved to a time in which there were no suitable treatment for atherosclerosis and other non-communicable diseases, or at least, much deeper knowledge is required to manage these diseases. In this context, the trajectory has been long and successful, mainly due to the quality of the human and material resources arranged and leadership to meet planned goals. As a result of combined work, the Unit has trained many PhD students with successful careers in clinical research and have been published more than 400 articles, as well as books, book chapters, clinical guides, and other teaching material. The key to lead clinical and research teams is relatively simple when considering and taking advantage of the ideas and abilities of each member, managing emotions and maintaining goals oriented to motivate continuous improvement. The Unit has demonstrated ability to manage more than 80 projects including clinical trials, commitments to related Industries and academic competitive projects. The Unit has been steadily extending a complex collaboration network throughout Spain, Europe and the United States. The last 10 years have been oriented towards understanding obesity and its metabolic complications, especially diabetes, non-alcoholic fatty liver disease, cancer and arteriosclerosis, the leading causes of morbidity and mortality worldwide. It is now clear that deciphering key mechanisms coordinating nutrition, metabolism, epigenetics, oxidation and inflammation may lead to combined and effective treatments. Current challenges include the understanding of the metabolo-epigenetics clues governing metabolic flexibility and disease-induced metabolic reprogramming. In pursuing these goals, we have learned, not without fuss, that working alone allows reaching limited goals more quickly and without excessive effort, but that we go much further by forming multidisciplinary teams.
研究兴趣
论文共 304 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Meritxell Arenas, Maria Fargas-Saladie, Marta Moreno-Sole, Lucia Moyano-Femenia,Andrea Jimenez-Franco, Marta Canela-Capdevila,Helena Castane, Cristian Martinez-Navidad,Jordi Camps,Jorge Joven
HELIYONno. 1 (2024): e23628-e23628
CRC Press eBookspp.723-726, (2023)
引用0浏览0引用
0
0
B.A. Malave Chacon, J.C. Acosta Arteaga,B. Piqué, L. Torres-Royo,E. Rodríguez-Tomás, R. Benavides, G. De Febrer, P. Araguas, J.A. Gomez, M. Arquez, V.D. Calderon, M. Algara,
Radiotherapy and Oncology (2023): S815-S816
Chemico-Biological Interactions (2023): 110553-110553
Berta Piqué,Karla Peña,Francesc Riu,Johana C Acosta, Laura Torres-Royo,Barbara Malave,Pablo Araguas, Rocío Benavides, Gabriel de Febrer,Jordi Camps,Jorge Joven,Meritxell Arenas,
Simona Iftimie,Ana F López-Azcona,María José Lozano-Olmo, Àngels Naval-Ferrando, Vicent Domingo-Cortés,Helena Castañé,Andrea Jiménez-Franco,Anna Hernández-Aguilera,Carmen Guilarte,Francesc Riu,Jordi Camps,Jorge Joven,
Eugenia Espinel,María Antonia Azancot,Alba Gomez,Anna Beneria, Anna Caraben, Laura Andurell,Pilar Delgado,Helena Castañé,Jorge Joven,Daniel Seron
Cristian Martinez Navidad, Cristina Placed,Helena Castane,Andrea Jimenez Franco,Jordi Camps,Jorge Joven
JOURNAL OF HEPATOLOGY (2023): S670-S671
引用0浏览0引用
0
0
Jordi Camps,Simona Iftimie,Ana F. López‑Azcona,Maria José Lozano‑Olmo , Àngels Naval-Ferrando, Vicent Domingo-Cortés,Helena Castañé,Andrea Jiménez-Franco,Anna Hernández-Aguilera,Carmen Guilarte,Francesc Riu,Jorge Joven,
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn